Diabetes

Thought-provoking economic, ethical conundrums accompany recent explosion in growth of glucagon-like peptide-1 products for medically assisted weight loss

On March 1, 2023, Eli Lilly and Company said it would take steps to cap insulin prices, and Novo Nordisk and Sanofi followed suit 2 weeks later.

Asian Americans often develop the disease at a normal weight, which would be overlooked by current screening guidelines, investigators say.

CGM devices can also help individuals with diabetes make more informed decisions about their diet, exercise, and medication management, leading to improved overall health outcomes.

There has not yet been established a consensus on the set of factors to use for assessing social determinants of health in practice.

It is important for pharmacists to understand implications related to drug clearance to maximize therapeutics in patients with kidney disease.

Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.

The changes, which will be effective January 1, 2024, include pre-filled pens, vials of basal, vials of bolus, and pre-mix insulins.

Patients with diabetes who followed a plant-based, low-carbohydrate diet and participated in healthy lifestyle habits experienced the most health benefits.

Molecular complexes can serve as a D-glucose chemical sensor with chiral selectivity and sensitivity to improve diabetes testing.

The application is based on phase 3 results from the DINAMO trial showing that Jardiance tablets significantly reduced A1C levels vs a placebo in participants aged 10 to 17 years.

Donna Ryan, MD, discussed her presentation about pharmacological approaches for obesity, which patients they are indicated for, and considerations for pharmacists.

Pharmacists play a vital role in ensuring that patients can afford their medications, either by advising them on more affordable options or working with insurers and prescribers to find cheaper alternatives.

Although scientists have long been working on anti-obesity medications, several key failures in recent decades have made this a challenge.

In an interview with Pharmacy Times, Anastasia Armbruster, PharmD, FACC, BCCP, discussed her presentation at the American College of Cardiology 2023 Scientific Session.

The company is also launching Rezvoglar, a biosimilar to Lantus injection, for $92 per 5-pack of KwikPens.

Aflibercept injection (8 mg) in a 12-week dosing regimen was found non inferior in vision gains compared to 8-week dosing regimen with 2 mg.

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Findings highlight the need for evidence-based strategies to avoid being obese or overweight for patients with type 1 diabetes, which is often considered a disease of thin individuals.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Declining and inconsistent use of blood-pressure, glucose-, and lipid-lowering medications for those with type 2 diabetes suggests treatment gaps, investigators say.

Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms.

More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.

Study results indicate that exercising, following a high-quality diet, limiting alcohol intake, maintaining a healthy body weight, and not smoking protects those with type 2 diabetes.